SEC Form 4 · accession 0001104659-18-036324
Nabriva Therapeutics plc · NBRV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francesco Maria Lavino
Officer — Chief Commercial Officer
Period of report
May 23, 2018
Accepted (ET)
May 29, 2018 · 1:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641640
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | May 23, 2018 | P | 2,160 | $4.60 | A | 3,719 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction is being reported late due to an administrative oversight.